|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Hepion Pharmaceuticals (NASDAQ: HEPA) through any online brokerage.
The latest price target for Hepion Pharmaceuticals (NASDAQ: HEPA) was reported by Brookline Capital on November 22, 2019. The analyst firm set a price target for 12.00 expecting HEPA to rise to within 12 months (a possible 476.92% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $2.08 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Hepion Pharmaceuticals.
There is no upcoming split for Hepion Pharmaceuticals.
Hepion Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.